Myelodysplastic syndromes occur mainly in older persons, and these patients are likely to have comorbidities that significantly worsen their survival. In this perspective article, Drs. Della Porta and Malcovati examine the relevance of comorbidities for clinical decision making in patients with myelodysplasti syndromes.
Clinical relevance of extra-hematologic comorbidity in the management of patients with myelodysplastic syndrome.
DELLA PORTA, MATTEO GIOVANNI;
2009-01-01
Abstract
Myelodysplastic syndromes occur mainly in older persons, and these patients are likely to have comorbidities that significantly worsen their survival. In this perspective article, Drs. Della Porta and Malcovati examine the relevance of comorbidities for clinical decision making in patients with myelodysplasti syndromes.File in questo prodotto:
Non ci sono file associati a questo prodotto.
I documenti in IRIS sono protetti da copyright e tutti i diritti sono riservati, salvo diversa indicazione.
